Purpose: To determine if ocular treatment with topically administered prostamide or prostaglandin analogs can reduce central corneal thickness (CCT). Methods: We retrospectively analyzed the data of glaucomatous patie...Purpose: To determine if ocular treatment with topically administered prostamide or prostaglandin analogs can reduce central corneal thickness (CCT). Methods: We retrospectively analyzed the data of glaucomatous patients who had their CCT measured before and during monotherapy treatment with either latanoprost 0.05%, travoprost 0.004% or bimatoprost 0.03%. 62 patients were qualified for analysis. One eye of each subject was ran-展开更多
Purpose: Intraocular Pressure (IOP) control is the main goal in glaucoma treatment However, despite satisfactory control, the occurrence of side effects reduces compliance. This study was designed to test if an ophtha...Purpose: Intraocular Pressure (IOP) control is the main goal in glaucoma treatment However, despite satisfactory control, the occurrence of side effects reduces compliance. This study was designed to test if an ophthalmic preparation of 50% diluted bi-matoprost (bimatoprost 0.015%) achieves good IOP展开更多
Purpose: To determine if there is an influence of the Water Drinking Test (WDT) on central corneal thickness (CCT) due to the sudden change of osmolarity since an increase on CCT could lead to a false higher IOP readi...Purpose: To determine if there is an influence of the Water Drinking Test (WDT) on central corneal thickness (CCT) due to the sudden change of osmolarity since an increase on CCT could lead to a false higher IOP reading on applanation tonometry. Methods: 38 glaucomatous or glaucomatous suspect patients without ocular hypotensive medication were submitted to WDT. CCT was measured by ultrasound pachymetry before and展开更多
文摘Purpose: To determine if ocular treatment with topically administered prostamide or prostaglandin analogs can reduce central corneal thickness (CCT). Methods: We retrospectively analyzed the data of glaucomatous patients who had their CCT measured before and during monotherapy treatment with either latanoprost 0.05%, travoprost 0.004% or bimatoprost 0.03%. 62 patients were qualified for analysis. One eye of each subject was ran-
文摘Purpose: Intraocular Pressure (IOP) control is the main goal in glaucoma treatment However, despite satisfactory control, the occurrence of side effects reduces compliance. This study was designed to test if an ophthalmic preparation of 50% diluted bi-matoprost (bimatoprost 0.015%) achieves good IOP
文摘Purpose: To determine if there is an influence of the Water Drinking Test (WDT) on central corneal thickness (CCT) due to the sudden change of osmolarity since an increase on CCT could lead to a false higher IOP reading on applanation tonometry. Methods: 38 glaucomatous or glaucomatous suspect patients without ocular hypotensive medication were submitted to WDT. CCT was measured by ultrasound pachymetry before and
